Temporary cardiac support by VA-ECLS can lead to lower limb ischemia. The aim of this study is to evaluate a multi-modal strategy (physical examination, NIRS monitoring and angiography through the reperfusion canula) of lower limb surveillance.
VA ECLS is used as a temporary circulatory support during cardiogenic shock and refractory cardiac arrest. Complications of VA ECLS include hemorrhagic, infectious and ischemic events. VA ECLS requires arterial and venous canules which are frequently positioned in the femoral artery and vein, which carries the risk of lower limb ischemia due to retrograde flow and obstruction of the femoral artery lumen. VA ischemia during VA ECLS is frequent (11-52%) and requires the use of reperfusion canula in the femoral common artery on VA ECLS implantation in a primary prevention strategy, before lower limb ischemia occurs. Even with this strategy, lower limb ischemia can occur due to arterial thrombosis, arterial spasm or insufficient blood flow through the reperfusion canula. Lower limb complications are prevented by monitoring of regional oxygen saturation, control of the reperfusion canula position (ultrasound, angiography) and rapid management when lower limb ischemia is suspected. There are no clear recommendations regarding prevention of lower limb complications during VA ECLS and arterial angiography has been described to diagnose ischemic events and evaluate the effectiveness of an intervention such as injection of vasodilators. This study is a prospective evaluation of a strategy to prevent lower limb complications during VA ECLS with a systematic arterial angiography on VA ECLS implantation and when lower limb ischemia is suspected (regional oxygen tissue saturation \<50% or a differential \>15% between both lower limbs) in addition to continuous NIRS monitoring of lower limbs during VA ECLS.
Study Type
OBSERVATIONAL
Enrollment
40
Data collection only (lower limb angiography, lower limbs NIRS values).
CHU de Nancy
Nancy, France
Severe limb ischemia
Ischemia leading to surgical intervention, functional sequelae, necrosis of the extremities or compartment syndrome
Time frame: 60 days
Mortality
Mortality rate
Time frame: 28 days and 60 days
Incidence of ischemia of the lower limb during ICU stay
StO2 \< 50% during 4 consecutive minutes AND/OR StO2 differential \> 15% during ICU stay
Time frame: 2 months
Incidence of renal replacement therapy during ICU stay
Number of patients who underwent renal replacement therapy
Time frame: 2 months
Duration of ICU stay
Number of days in the ICU
Time frame: 60 days
Duration of hospital stay
Number of days in the hospital
Time frame: 60 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.